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ABSTRACT
The application of a particular concentration of neomycin solution to the forearm skin of
ten normal subjects caused in six subjects pyoderma due to neomycin resistant S. aureus.
Moreover, Candida parapsilosi. became abundant in eight. Although neither pyoderma nor
moniiasis is a likely complication of topical neomycin in the clinical setting, this experi..
mental observation further documents the principle that the normal microflora prevents
the establishment of potentially pathogenic species; elimination of resident organisms by
antibiotics creates an ecologic vacuum which inevitably becomes occupied by resistant
bacteria or fungi.
The rise in the rate of appearance of new
drugs over the past several decades has been
paralleled by an increase in the variety of wholly
unintended and unpredicted side effects. It is
now appreciated that there are many different
ways, often complex and indirect, in which the
administration of a drug may lead to the induc-
tion of a pathological state (1). With antibiotics,
as with all drugs, many types of reactions occur
based on diverse immunologic and toxic mecha-
nisms; however, one variety is peculiar to anti-
biotics, namely, the disruption of ecologic bal-
ances between the host and its microbial flora.
Suppression of the normal bacterial population
may lead to overgrowth of a potentially patho-
genic flora; susceptible organisms decline and
resistant strains become dominant. Thus elimina-
tion of a gram positive flora may be followed by
emergence of a dominantly gram negative one,
or fungi may replace bacteria, or virulent cocci
may displace non-virulent strains. Many such
instances are known after oral antibiotic treat-
ment in the nose (2), mouth (3), respiratory
tract (4),and intestine (5).
Less well appreciated are examples of harm
which arise when topical antibiotics cause eco-
logic shifts in the cutaneous microflora. A vivid
example is pseudomonal intertrigo of the toe web
following frequent washing with a soap contain-
ing a bacteriostat capable of depopulating the
resident gram positive flora (6). The normal
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population is a barrier to the invasion of foreign
strains (4). The way in which microbial species
interact needs to be much better understood.
In a study of the effect of topical neomycin
on the cutaneous flora, we unexpectedly en-
countered reactions which enlarged our ecologic
knowledge. Neomycin is perhaps the most ex-
tensively used topical antibiotic, even having
made its way into cosmetics and deodorants
(7). Although resistant strains of S. aureus have
increased, we know of no example in which
staphylocoecal pyoderma has followed topical
application of neomycin to normal skin (8). We
record our experience of this event, not because
pyoderma is likely to occur in ordinary practice
but because it emphasizes the importance of bac-
terial ecology in the maintenance of skin health.
These observations illustrate a principle and are
not intended as a warning against the employ-
ment of topical antibiotics.
METHODS
The subjects were ten healthy adult male pris-
oners. Two ml of a 1% aqueous solution of neo-
inycin sulfate was pipetted over the surface of one
forearm so as to give a surface dose of about 40
/Lgm/cm2. Two ml of water was similarly applied
to the opposite control arm. An impermeable
plastic film (Saran Wrap®) was then wound
around the arm several times and secured firmly
by adhesive tape to ensure complete occlusion.
This dressing was maintained for seven days dur-
ing which time it was replaced twice without
adding additional neomycin. Immediately after
removing the wrapping, the volar forearm was
sampled using the detergent scrub technique of
Williamson and Kligman (9). Appropriate dilu-
tions were plated as pour plates in Trypticase Soy
Agar (Difco) and in the same medium supple-
mented with 1% 'Tween 80' (Atlas Chem) as a
growth factor for lipophilic diphtheroids. Surface
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inoculation of solid trypticase soy agar was also
performed. The plates were incubated aerobically
for 48 hours at 37°. A Quebec colony counter was
used for counting.
The organisms were classified into the following
groups, based upon morphology and biochemical
tests: 1) 1S. aureus 2) Coagulase negative cocci 3)
lipophiic diphtheroids (lipo dip) 4) other aerobic
diphtheroids (dip) 5) gram negative rods and 6)
yeasts.
RESULTS
Occlusion had the expected effect on the con-
trol arm of stimulating the resident organisms
to multiply to a high population density (10).
The median bacterial count of normal forearm
skin is about one thousand bacteria per sq. cm.
This increased to more than a million in all cases
but one (Table I). In six, diphtheroids dominated
the flora, (more than 50% of the total count),
and in four, coagulase negative cocci were most
numerous. These two groups together made up
nearly all of the microflora in every instance.
Gram negative rods were recovered in low num-
bers from five arms; these included Proteus,
Alcaligene.s, Pseudomonas and Enterobacter spe-
cies. S. aureus was isolated once.
The antibiotic treated forearms were star-
tlingly different. Coagulase negative cocci and
diphtheroids were markedly reduced in num-
bers or eradicated; in their place S. aureus
emerged as the dominant organism in seven of
the ten arms and yeasts in the remaining three;
these were identified as Candida parapsilosis.
Substantial numbers of S. aureus were also pres-
ent in the three sites with yeast dominance and,
conversely, yeasts were recovered from five of
the seven dominantly S. aureus sites. Thus S.
aureus greatly proliferated in all ten cases, and
the yeast in eight.
Both the yeasts and the S. aureus strains were
resistant to 30 pgm neomycin discs in vitro. The
total count was approximately the same on both
arms although the species were entirely differ-
ent.
Especially notable was the presence of an
erythematous vesiculopapular diffuse rash in six
of the seven sites in which 8, aureus was domi-
nant. At first we thought this to be miliarial or
even contact allergy. However, biopsy in three
instances excluded these possibilities. The sweat
ducts were not involved and contact allergy
could not be envisioned in the face of great
numbers of polymorphonuclear leukocytes. The
absence of subcorneal pustules argued against
moniliasis. The general picture was one that we
have come to recognize as typical of experimen-
tal S. aureus infection, the features of which will
be described in another communication. Promi-
nent findings were intra-epidermal vesicles con-
taining lymphocytes and polymorphonuclear
leukocytes, toxic degeneration of the outer epi-
TABLE I
Neoniycin Control
Subject
Aerobic count DOmmant Others Aerobic count Others
1 78.0 >< 10 S. aureus Yeasts 4.23 X 10' Coag. neg.
staph.
Dip, Pseudomonas
2 39.8 X 10 S. aureus Yeasts 2.42 X 10 Lipo. dip Proteus
3 4.84 >( 10 S. aureus 5.26 X 10' Lipo. dip Coag. neg. staph.4 0.1 X 10' S. aureus 0.063 X 10' Coag. neg.
staph.
Lipo. dip.
5 22.4 X 10' 5. aureus Yeasts 16.71 )< l0 Lipo. dip Other dip., Proteus
6 5.3 X 106 5. aureus Yeasts
A icaligenes
9.79 X 10' Coag. neg.
staph.
Lipo. dip, Enterobacter
7 0.79 )< l0 Yeasts 5. aureus 7.9 X 106 Diphtheroid Lipo. dip, coag. neg.
staph.
8 3.8 X 10° Yeasts S. aureus 26.7 X 10' Lipo. dip Yeasts, S. au7ens
9 11.4 X 106 5. aureus Yeasts
A icali genes
36.0 X 10' Lipo. dip Coag. neg. staph.
.4 Icaligenes
10 1.01 X 106 Yeasts S. aureus 1.54 X 10 Coag. neg.
staph.
Lipo. dip.
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dermis, exocytosis by polymorphonuclear leu-
kocytes, dilated or hemorrhagic vessels with a
diffuse infiltrate of polymorphs and lymphocytes
in the epidermis.
This eruption subsided when occlusion was
ended. However in 4 of the 6 subjects sampled
two weeks later S. aureus was present in low
numbers.
OISCUSSION
It was not our object to produce infection.
Several agencies combined to produce this un-
usual result. First, the neomycin dose happened
to be of the right order of magnitude. In a simi-
lar study in which the skin concentration of neo-
mycin was three times greater, resistant S. aureus
appeared in only one of ten subjects, and C. para-
psilosis was practically the sole occupant in the
remaining nine. Evidently the surface concen-
tration was then so high that all bacteria were
suppressed and yeasts could grow without sig-
nificant bacterial competition. Secondly this in-
vestigation was conducted in an institution where
many subjects had been experimentally contact
sensitized to neomycin. The common use of neo-
mycin at the time of this study may have in-
creased the prevalence of resistant strains, es-
pecially since there was ample amounts of
eczematous soil in which such strains could pro-
liferate.
In studies of experimental S. aureus infection,
we have found the minimum infective dose to be
about 10,000 organisms per sq. cm. Nothing like
this quantity could have been present on the
normal skin of our subjects. However, this level
might be quickly exceeded if a few resistant
staphylococci happened to be present at the time
neomycin was applied. With the normal diph-
theroids and cocci suppressed, a few resistant
organisms would soon become dominant. In fact,
one can exploit this knowledge to induce ex-
perimental S. aureus pyoderma with as little as
a hundred resistant organisms.
We doubt that clinicians need seriously antici-
pate S. aureus pyoderma in patients using topi-
cal neomycin. The commercial strengths usually
are 0.5% or greater and the quantity applied is
very much larger, amounts too high to permit
multiplication of S. aureus even if these were
both numerous and resistant. it is somewhat sur-
prising, however, that moniliasis is not a more
frequent complication; an earlier report of this
has not been confirmed (11). It is clear, how-
ever, that yeasts will rapidly occupy regions from
which bacteria have been expelled. Perhaps, as
in our cases, the supplanting yeast is one less
virulent than C. albicans.
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